At a glance
ClinicalIndex Comparison RecordN/ACompleted· 8 enrolled
Drug / intervention
Computed tomographyradiation
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Investigating the Effect of Nasal High Flow Oxygen Therapy on Regional Lung Function
In Brief
A clinical study evaluating Computed tomography for Chronic Obstructive Pulmonary Disease and 2 related conditions. Completed, enrolled 8 participants across 1 site.
Detailed Summary
This study aims to assess the effect of nasal high flow oxygen therapy on regional function measured by volumetric computed tomography, in patients with chronic obstructive pulmonary disease.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsChronic Obstructive Pulmonary Disease, Nasal High Flow, Dynamic Volumetric Computed Tomography
CountriesFrance
Collaborators--
Timeline
N/ACompletedFinished
20192020202120222023202420252026
Enrollment StartDec 2018
First PostedJan 2019
Primary CompletionJun 2019
TodayJul 2026
First PostedJan 29, 2019
Enrollment StartDec 6, 2018
Primary CompletionJun 18, 2019
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 7.4 years ago
Interventions
Computed tomographyradiation
End-inspiratory/end-expiratory CT is repeated 3 times corresponding to the 3 studied conditions: At baseline, through expiratory resistive loading using an adjustable PEP mask, and after 5 min of nasal high flow therapy at 25 L/min.